July 20 Web Event: Medication Abortion in a Post-Roe v. Wade America July 20, 2022 Event Medication abortion, also known as medical abortion or abortion with pills, has been FDA-approved as safe and effective since 2000 for the termination of pregnancies through the first 10 weeks. Its use in the United States has grown in recently years and now it accounts for just over half of…
Reading the Post-Roe Tea Leaves in States Without Abortion Bans or Protections June 23, 2022 Blog In the 17 states without explicit laws prohibiting or protecting abortions, we present a number of indicators to assess abortion access, including abortion restrictions, the number of clinics and women of reproductive age per clinic, as well as State Supreme Court rulings interpreting the right to abortion in that state.
KFF Health Tracking Poll: Views on and Knowledge about Abortion in Wake of Leaked Supreme Court Opinion June 9, 2022 Poll Finding This poll analyses the general public’s understanding of abortion access and reproductive health following a leaked draft of the U.S Supreme Court opinion on Dobbs v. Jackson Women’s Health Center. The poll also looks at how the aftermath of the leaked opinion may affect voting in the upcoming midterm election. This KFF poll also finds that there are significant knowledge gaps on the prevalence and the overall safety of abortions.
June 9 Web Event: Americans’ Knowledge and Attitudes About Abortion Access and the Pending Supreme Court Ruling June 9, 2022 Event On June 9, KFF released findings from a national public opinion survey on abortion. The event highlighted key issues including awareness and attitudes of the impending Supreme Court opinion, its potential impact on abortion access, the importance of abortion policy to voting preferences in this year’s midterm elections, and knowledge of abortion and related health care.
Update on the Status of Medication Abortion and the Courts April 21, 2023 Blog This policy watch explains the April 21, 2023 United States Supreme Court’s ruling on Alliance for Hippocratic Medicine v. FDA, a case challening the FDA’s approval of mifepristone, the medication abortion pill.
Q & A: Implications of Two Conflicting Federal Court Rulings on the Availability of Medication Abortion and the FDA’s Authority to Regulate Drugs April 8, 2023 Blog This policy watch explains the two conflicting rulings on the provision of mifepristone issued by two separate District Courts on April 7, 2023, Alliance for Hippocratic Medicine v. FDA and State of Washington v. United States Food and Drug Administration.
Medication Abortion in the Courts: What’s at Stake? March 8, 2023 News Release Access to medication abortion has emerged as a central issue following the Dobbs decision overturning Roe v. Wade. There is ongoing litigation in four federal cases about the FDA’s approval and regulation of mifepristone, one of the two drugs used in medication abortion. Mifepristone, approved by the FDA in 2000,…
The Public, Including Women of Childbearing Age, Are Largely Confused About the Legality of Medication Abortion and Emergency Contraceptives in Their States February 1, 2023 News Release More than six months since the Supreme Court issued their Dobbs decision which overturned Roe v. Wade, there is widespread public confusion about the medication abortion pill and whether it is legal at the state level, according to the latest KFF Health Tracking Poll. The poll also finds many are…
KFF Health Tracking Poll: Early 2023 Update On Public Awareness On Abortion and Emergency Contraception February 1, 2023 Poll Finding Following the FDA approval of retail pharmacies carrying and distributing medication abortion, this poll finds that the public’s awareness and knowledge of emergency contraception and medication abortion is still lacking, especially among respondents living in states with full abortion bans.
Dec. 13 Web Event: What is the future of contraceptive care in a post-Roe world? December 13, 2022 Event The Supreme Court’s decision to overturn Roe v. Wade and subsequent state abortion bans have moved the issue of access to high-quality and affordable contraceptive care to the forefront. As these seismic shifts shape women’s health care in the United States, the FDA is considering an application for a daily…